Medtronic Price to Free Cash Flow Ratio 2010-2025 | MDT
Historical price to free cash flow ratio values for Medtronic (MDT) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medtronic Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-23 | 80.68 | 19.24 | |
| 2025-01-31 | 90.11 | $4.19 | 21.49 |
| 2024-10-31 | 87.79 | $4.16 | 21.10 |
| 2024-07-31 | 78.39 | $3.88 | 20.21 |
| 2024-04-30 | 77.62 | $3.91 | 19.86 |
| 2024-01-31 | 83.98 | $3.70 | 22.70 |
| 2023-10-31 | 67.13 | $3.03 | 22.12 |
| 2023-07-31 | 82.79 | $3.33 | 24.83 |
| 2023-04-30 | 85.13 | $3.44 | 24.77 |
| 2023-01-31 | 77.67 | $3.11 | 25.00 |
| 2022-10-31 | 80.34 | $3.59 | 22.40 |
| 2022-07-31 | 84.43 | $4.24 | 19.90 |
| 2022-04-30 | 94.51 | $4.42 | 21.36 |
| 2022-01-31 | 93.16 | $4.21 | 22.15 |
| 2021-10-31 | 107.22 | $4.26 | 25.17 |
| 2021-07-31 | 116.88 | $4.32 | 27.04 |
| 2021-04-30 | 115.95 | $3.61 | 32.14 |
| 2021-01-31 | 98.11 | $3.42 | 28.69 |
| 2020-10-31 | 88.19 | $3.52 | 25.08 |
| 2020-07-31 | 84.12 | $3.52 | 23.89 |
| 2020-04-30 | 84.57 | $4.46 | 18.98 |
| 2020-01-31 | 99.38 | $4.91 | 20.24 |
| 2019-10-31 | 93.30 | $4.65 | 20.05 |
| 2019-07-31 | 86.90 | $4.19 | 20.75 |
| 2019-04-30 | 75.29 | $4.33 | 17.40 |
| 2019-01-31 | 74.53 | $3.57 | 20.88 |
| 2018-10-31 | 75.31 | $3.56 | 21.14 |
| 2018-07-31 | 75.27 | $3.34 | 22.52 |
| 2018-04-30 | 66.46 | $2.64 | 25.14 |
| 2018-01-31 | 70.82 | $3.14 | 22.57 |
| 2017-10-31 | 66.02 | $3.12 | 21.14 |
| 2017-07-31 | 68.44 | $3.51 | 19.50 |
| 2017-04-30 | 67.38 | $4.04 | 16.66 |
| 2017-01-31 | 61.32 | $3.70 | 16.57 |
| 2016-10-31 | 65.76 | $3.51 | 18.72 |
| 2016-07-31 | 69.91 | $3.38 | 20.68 |
| 2016-04-30 | 62.83 | $2.93 | 21.48 |
| 2016-01-31 | 59.97 | $3.47 | 17.28 |
| 2015-10-31 | 58.10 | $4.04 | 14.38 |
| 2015-07-31 | 61.28 | $4.12 | 14.88 |
| 2015-04-30 | 57.90 | $3.91 | 14.83 |
| 2015-01-31 | 55.31 | $3.88 | 14.25 |
| 2014-10-31 | 52.58 | $3.72 | 14.15 |
| 2014-07-31 | 47.40 | $3.82 | 12.42 |
| 2014-04-30 | 44.94 | $4.50 | 9.98 |
| 2014-01-31 | 43.02 | $4.40 | 9.77 |
| 2013-10-31 | 43.44 | $4.21 | 10.32 |
| 2013-07-31 | 41.59 | $4.07 | 10.23 |
| 2013-04-30 | 34.95 | $4.37 | 8.01 |
| 2013-01-31 | 34.70 | $4.15 | 8.36 |
| 2012-10-31 | 30.78 | $3.82 | 8.05 |
| 2012-07-31 | 29.00 | $4.02 | 7.21 |
| 2012-04-30 | 27.92 | $3.76 | 7.42 |
| 2012-01-31 | 28.02 | $3.50 | 8.01 |
| 2011-10-31 | 25.08 | $3.56 | 7.04 |
| 2011-07-31 | 25.82 | $3.28 | 7.88 |
| 2011-04-30 | 29.72 | $3.00 | 9.92 |
| 2011-01-31 | 27.12 | $3.34 | 8.13 |
| 2010-10-31 | 24.78 | $3.52 | 7.03 |
| 2010-07-31 | 25.83 | $3.42 | 7.54 |
| 2010-04-30 | 30.34 | $3.21 | 9.46 |
| 2010-01-31 | 29.65 | $3.13 | 9.47 |
| 2009-10-31 | 24.56 | $4.02 | 6.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $103.476B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |